Thus, the high expression of SH3KBP1 in GBM may be attributed to SOX10 high expression in GBM and the mechanisms mediating SH3KBP1 overexpression in glioma and GSCs needs further characterized. This evidence concerns the gene SOX10 and central nervous system cancer.